fluorouracil has been researched along with laq824 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Atadja, P; Bair, K; Chandramouli, N; Cohen, D; Gao, L; Hsu, M; Kwon, P; Lassota, P; Perez, L; Remiszewski, S; Sambucetti, L; Trogani, N; Versace, R; Walker, H; Wood, A; Wu, A; Yeleswarapu, L | 1 |
2 other study(ies) available for fluorouracil and laq824
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Enzyme Inhibitors; Fluorouracil; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Kinetics; Male; Mice; Promoter Regions, Genetic; Transplantation, Heterologous | 2004 |